News & Public Events

Drug developers can't take an adult clinical trial protocol and just retool it for pediatrics. Yet in my work at a pediatric clinical research organization (CRO), I frequently see sponsors attempt to do just that. Successfully implementing a pediatric drug development plan poses challenges regarding trial planning, design, and conduct. In this blog post, I’ll discuss these challenges and propose some tips for addressing them. Click Here to Read the Blog ...

Read More

Paidion CEO Barry Mangum shares invaluable insights on FDA expectations of pediatric programs. This is the second of three blog posts based on a recent webinar he presented in partnership with Certara, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. Click here to read the Blog. ...

Read More

Paidion CEO Barry Mangum shares invaluable insights on FDA expectations of pediatric programs. This is the first of three blog posts based on a recent webinar he presented in partnership with Certara, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. Click here to read the Blog.

Read More

Paidion was recently featured in an article published in the Triangle Business Journal. Click here to read the article.

Read More

A paper co-authored by Paidion CEO Dr. Barry Mangum was presented at the Hot Topics in Neonatology conference, December 6 - 9 in Washington, DC, an event that annually gathers more than 1000 neonatologists and perinatologists. The poster “Risk Assessment Based on In Vitro Testing to Evaluate Compatibility of Recombinant IGF-1/IGFBP-3 with Intravenous Medications Commonly Administered in the Neonatal Environment” summarized results from a study sponsored by Shire, a global innovato...

Read More

While the statistics are sobering, the optimism is soaring. Every year worldwide, 15 million babies are born prematurely. In the US, 1 in 10 come too soon. More than a million lose the tough battle to survive and many of those who do make it end up with lifelong health challenges. On November 17 World Prematurity Day, Paidion chooses to honor families everywhere by not changing a single thing: we are, and always will be, absolutely, fiercely dedicated to the health and well-being of chil...

Read More

Renee loves babies. Literally. It’s her job as a NICU nurse. She does everything she can to give them–and their families–the care and, most important of all, the hope they deserve. Just like us. Paidion Research, Inc. is in the tiny miracles business. We’re proud of all we do–assisting in the advanced research and ground-breaking drug development efforts exclusively for pediatrics–to help all the Renees around the world make a difference in the lives o...

Read More

PRINCETON, NJ and DURHAM, NC – Sept. 10, 2015 – Certara®, the global biosimulation technology-enabled drug development company, and Paidion Research, Inc., a pediatric clinical research organization (CRO), today announced a new partnership dedicated to promoting more efficient and reliable drug development for pediatric patients. The partnership harnesses Certara’s unmatched biosimulation (modeling and simulation) and regulatory writing capabilities, with Paidion’s...

Read More

Barry Mangum, PharmD, FCP, Co-Founder and CEO of Paidion Research, Inc., a new clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), was a presenter at the 51st Drug Information Association (DIA) Annual Meeting in Washington, DC in mid-June. The DIA is a global organization of life science professionals involved in the discovery, development and life cycle management of therapeutic and heal...

Read More

Preclinical data suggest that the loop-diuretic bumetanide might be an effective treatment for neonatal seizures. The study aimed to assess dose and feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizures. Dr. Mangum co-authored this study which was published in the May 2015 issue of Lancet Neurology. [Vol. 14 | Number 5 | May 2015] Click Here to Read the Article: http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70303-5/ab...

Read More

Destrey Roberson was recently named Vice President of Clinical Operations of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered in Durham, NC, the innovative company provides its drug and device development partners comprehensive global services including pharmacometrics, innovative regulatory strategies and efficient, effective global trial execut...

Read More

(RESEARCH TRIANGLE PARK, NC) Paidion Research, Inc., a new clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), recently named Destrey Roberson Vice President of Clinical Operations. He brings significant NICU experience to Paidion including leadership of two of the largest, interventional NICU trials conducted (one with 1550 neonates in 92 NICUs in six countries and another with 200 neona...

Read More

Barry Mangum, PharmD, FCP has been named CEO of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered on Leigh Farm Road in Durham, the innovative company provides its drug and device development partners comprehensive global services including pharmacometrics, innovative regulatory strategies and efficient, effective global trial execution. Resp...

Read More

(RESEARCH TRIANGLE PARK, NC) Barry Mangum, PharmD, FCP has been named CEO of Paidion Research, Inc., a clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered on Leigh Farm Road in Durham, the company provides its drug and device development partners comprehensive global services including pharmacometrics, innovative regulatory strategies and efficient, effective global trial ex...

Read More

Because children respond to medical treatments differently than adults, drug development and testing for kids also should be different. Paidion Research, Inc. is a new clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care). Headquartered in Durham, NC, Paidion combines pediatric clinical pharmacology expertise with innovative pediatric regulatory strategies and trial methodologies to provide ...

Read More

(RESEARCH TRIANGLE PARK, NC) Paidion Research, Inc., a new clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), recently opened for business. Headquartered on Leigh Farm Road in Durham, Paidion combines pediatric clinical pharmacology expertise with innovative pediatric regulatory strategies and trial methodologies to provide best-in-class service to drug and device development partners in...

Read More